These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33931292)

  • 1. Response to letter to the editor: Appropriate data synthesis provide reliable evidence regarding efficacy of FOY in preventing post endoscopic retrograde cholangiopancreatography pancreatitis.
    Kang YN; Chang CC
    J Formos Med Assoc; 2021 Sep; 120(9):1798-1799. PubMed ID: 33931292
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of gabexate mesilate in preventing post endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis of randomized clinical trials.
    Chiu YJ; Chen SC; Kang YN; Hou SK; Chao CC; Chang CC
    J Formos Med Assoc; 2021 Apr; 120(4):1090-1099. PubMed ID: 33183879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of gabexate mesilate in preventing post endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis of randomized clinical trials.
    Xie J; Li L
    J Formos Med Assoc; 2021 Sep; 120(9):1796-1797. PubMed ID: 33895063
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Xiong GS; Wu SM; Zhang XW; Ge ZZ
    Braz J Med Biol Res; 2006 Jan; 39(1):85-90. PubMed ID: 16400468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial.
    Ueki T; Otani K; Kawamoto K; Shimizu A; Fujimura N; Sakaguchi S; Matsui T
    J Gastroenterol; 2007 Feb; 42(2):161-7. PubMed ID: 17351806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Could nafamostat or gabexate prevent the post endoscopic retrograde cholangiopancreatography pancreatitis?].
    Kwon YH; Kim JY; Lee SJ; Jang SY; Park HW; Yang HM; Jung MK; Jeon SW; Cho CM; Tak WY; Kweon YO; Kim SK
    Korean J Gastroenterol; 2012 Mar; 59(3):232-8. PubMed ID: 22460572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials.
    Rudin D; Kiss A; Wetz RV; Sottile VM
    J Gastroenterol Hepatol; 2007 Jul; 22(7):977-83. PubMed ID: 17559376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing pancreatitis after endoscopic retrograde cholangiopancreatography.
    Kubiliun NM; Elmunzer BJ
    Gastrointest Endosc Clin N Am; 2013 Oct; 23(4):769-86. PubMed ID: 24079789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-ERCP pancreatitis.
    Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: what can be done?
    Hauser G; Milosevic M; Stimac D; Zerem E; Jovanović P; Blazevic I
    World J Gastroenterol; 2015 Jan; 21(4):1069-80. PubMed ID: 25632179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing Postendoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Elmunzer BJ
    Gastrointest Endosc Clin N Am; 2015 Oct; 25(4):725-36. PubMed ID: 26431600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography.
    Schneider J; Barkin J
    Gastrointest Endosc; 1997 May; 45(5):447-8. PubMed ID: 9165340
    [No Abstract]   [Full Text] [Related]  

  • 13. Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination?
    Pezzilli R; Gabbrielli A; Labate AM; D'Alessio P; Barakat B; Costamagna G; Dibenedetti F; Massa M; Merlini G; d'Eril GM
    Hepatogastroenterology; 2003; 50(51):851-5. PubMed ID: 12828103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
    Cavallini G; Tittobello A; Frulloni L; Masci E; Mariana A; Di Francesco V
    N Engl J Med; 1996 Sep; 335(13):919-23. PubMed ID: 8786777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term prophylactic prevention of post-ERCP pancreatitis.
    Masci E; Mariani A
    Gastrointest Endosc; 2003 Nov; 58(5):816. PubMed ID: 14997914
    [No Abstract]   [Full Text] [Related]  

  • 16. Rectal indomethacin or intravenous gabexate mesylate as prophylaxis for acute pancreatitis post-endoscopic retrograde cholangiopancreatography.
    Guglielmi V; Tutino M; Guerra V; Giorgio P
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5268-5274. PubMed ID: 29228444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
    BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to Avoid Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Leerhøy B; Elmunzer BJ
    Gastrointest Endosc Clin N Am; 2018 Oct; 28(4):439-454. PubMed ID: 30241637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
    Andriulli A; Solmi L; Loperfido S; Leo P; Festa V; Belmonte A; Spirito F; Silla M; Forte G; Terruzzi V; Marenco G; Ciliberto E; Sabatino A; Monica F; Magnolia MR; Perri F
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):713-8. PubMed ID: 15290665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproteases in preventing post-ERCP acute pancreatitis.
    Tsujino T; Kawabe T; Omata M
    JOP; 2007 Jul; 8(4 Suppl):509-17. PubMed ID: 17625308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.